Sierra Oncology, Inc. Debt to Equity Ratio 2015-2022 | SRRA
Current and historical debt to equity ratio values for Sierra Oncology, Inc. (SRRA) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Sierra Oncology, Inc. debt/equity for the three months ending March 31, 2022 was .
Debt/Equity Ratio Historical Data |
Date |
Long Term Debt |
Shareholder's Equity |
Debt to Equity Ratio |
2022-03-31 |
$0.02B |
$0.26B |
0.07 |
2021-12-31 |
$0.01B |
$0.10B |
0.14 |
2021-09-30 |
$0.01B |
$0.10B |
0.10 |
2021-06-30 |
$0.01B |
$0.08B |
0.12 |
2021-03-31 |
$0.01B |
$0.10B |
0.09 |
2020-12-31 |
$0.01B |
$0.10B |
0.10 |
2020-09-30 |
$0.01B |
$0.11B |
0.07 |
2020-06-30 |
$0.01B |
$0.12B |
0.08 |
2020-03-31 |
$0.01B |
$0.13B |
0.06 |
2019-12-31 |
$0.07B |
$0.09B |
0.75 |
2019-09-30 |
$0.01B |
$0.06B |
0.23 |
2019-06-30 |
$0.01B |
$0.07B |
0.19 |
2019-03-31 |
$0.01B |
$0.08B |
0.15 |
2018-12-31 |
$0.02B |
$0.09B |
0.16 |
2018-09-30 |
$0.01B |
$0.11B |
0.12 |
2018-06-30 |
$0.01B |
$0.12B |
0.07 |
2018-03-31 |
$0.01B |
$0.13B |
0.04 |
2017-12-31 |
$0.01B |
$0.10B |
0.08 |
2017-09-30 |
$0.01B |
$0.10B |
0.06 |
2017-06-30 |
$0.01B |
$0.11B |
0.05 |
2017-03-31 |
$0.01B |
$0.12B |
0.04 |
2016-12-31 |
$0.01B |
$0.10B |
0.08 |
2016-09-30 |
$0.01B |
$0.11B |
0.13 |
2016-06-30 |
$0.01B |
$0.13B |
0.06 |
2016-03-31 |
$0.01B |
$0.14B |
0.05 |
2015-12-31 |
$0.01B |
$0.15B |
0.05 |
2015-09-30 |
$0.00B |
$0.16B |
0.02 |
2015-06-30 |
$0.31B |
$-0.28B |
-1.11 |
2015-03-31 |
$0.16B |
$-0.13B |
-1.29 |
2014-12-31 |
$0.15B |
$-0.11B |
-1.38 |
2014-09-30 |
$0.00B |
|
0.00 |
2014-06-30 |
$0.00B |
|
0.00 |
2014-03-31 |
$0.00B |
|
0.00 |